Serkan Atici
DOI: jid.2020.4
Clinical Infectious Diseases: Open Access (ISSN: 2684-4559) is
growing continuously. It is our pleasure to announce that during year
2019, all issues of volume 3 were published online on time and the
print issues were also brought out and dispatched within 30 days of
publishing the issue online.
All published articles of this journal are included in the indexing
and abstracting coverage of CAS Source Index (CASSI), Index
Copernicus, Google Scholar, Sherpa Romeo, RefSeek, EBSCO A-Z,
OCLC- WorldCat, SWB online catalog, Publons, etc.
During the calendar year 2019, JID received a total of 7 papers,
out of which 1 article were rejected in the preliminary screening due
to plagiarism or being out of the format and peer review process.
During 2019 around 5 articles were subjected for publication after
they are accepted in the peer review process. In the 3 issues of
Volume 3 published during the year 2019, a total of 5 articles were
published (at an average of 2 articles per issue) of which, articles
were published from authors all around the world. Average
publication lag time of an article was further reduced to 2-3 weeks.
Clinical Infectious Diseases: Open Access its new association with
Hilaris Publishing group for Archiving, Journal maintenance,
financial purpose and support. Journal will be running its website
https://www.hilarispublisher.com/clinical-infectious-diseases.html
parallel for Editorial and review work process so as to maintain its
highest standard of scientific work.
Association with Hilaris Publishing Group has increased
Readership Metrics (By Google Analytics) of Clinical Infectious
Diseases: Open Access at the same.
Clin Infect Dis, an open accessjournal
I take this opportunity to acknowledge the contribution by Editors:
Dr. Pere Domingo, Associate Editors: Omer Faruk Ozkan and also
during the final editing of articles published and the support rendered
by the editorial assistants bringing out issues of JID in time. I would
also like to express my gratitude to all the Editors, authors, reviewers,
the publisher, the advisory, and the editorial board of JID, the office
bearers for their support in bringing out yet another volume of JID and
look forward to their unrelenting support to bring out the Volume 4
and upcoming Volume 5 of JID in scheduled time.
Nawal Brikci Nigassa and Mustapha Haddouche*
DOI: 10.37421/jid.2020.4.118/
Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern.
Its involves humans as well as animals and may cause serious damage to the respiratory tract, including the lung: coronavirus disease (COVID-19). This pathogenic virus
has been identified in swabs performed on the throat and nose of patients who suffer from or are suspected of the disease. Based on the large number of infected people
that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19.
